Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based global company with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis extracts. Ubiquo is a knowledge management and medical consultation system that aims to create access to healthcare for Colombians.


TSXV:PCLO - Post by User

Post by bronkrdron Dec 18, 2020 6:07pm
166 Views
Post# 32145457

Expansion of Retail Investor Relations

Expansion of Retail Investor Relations
PharmaCielo Colombia Holdings S.A.S. today announced that the company has expanded investor relations support capacity with the appointment of Caroline Lenardon to provide investor relations services to the Company with a focus on retail investment.  The institutional investor market will continue to be supported by the existing contractor.
<< Previous
Bullboard Posts
Next >>